Ovarian Cancer: Causes, Symptoms, and Treatment
This paper provides a comprehensive overview of ovarian cancer, the fifth most common cancer among women and the most frequent cause of gynecologic cancer death in the United States. It examines the known risk factors associated with the disease, including genetic mutations in BRCA1 and BRCA2, age, and reproductive history. The paper also outlines the vague and often overlooked symptoms that delay early diagnosis, the diagnostic tools available, and the standard treatment protocols — including surgery, platinum-based chemotherapy, and emerging therapies. Finally, it addresses prognosis, survival rates, and the ongoing challenge of ensuring that patients receive care from qualified gynecologic oncologists.
- Introduction to Ovarian Cancer: Overview, epidemiology, and U.S. prevalence statistics
- Risk Factors: Genetic, reproductive, and hormonal risk associations
- Signs and Symptoms: Vague symptoms that delay early detection
- Diagnosis: Tests, scans, and surgical diagnostic procedures
- Treatment Options: Surgery, chemotherapy, and emerging drug therapies
- Prognosis and Survival Rates: Survival statistics by stage at diagnosis
- Conclusion: The Struggle Continues: Gaps in care quality and public health advocacy
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper covers the full clinical arc of ovarian cancer — from risk factors and symptoms through diagnosis, treatment, and prognosis — giving readers a well-rounded understanding of the disease.
- It draws on multiple authoritative sources, including PubMed Health, The Lancet, and the National Cancer Institute's PDQ database, lending credibility to its claims.
- The concluding section effectively connects clinical data to a broader public health concern — the inadequate treatment many patients receive — giving the paper a policy-relevant dimension.
Key academic technique demonstrated
The paper demonstrates synthesis across multiple medical and epidemiological sources to build a coherent clinical picture. Rather than relying on a single source, it layers findings from peer-reviewed journals, government health databases, and epidemiological statistics to support each claim, a technique essential in health sciences writing.
Structure breakdown
The paper is organized into clearly labeled sections that follow a logical clinical progression: overview and epidemiology, risk factors, symptoms, diagnosis, treatment, and prognosis. It closes with a summary section that widens the lens to address systemic issues in patient care. Each section is concise and citation-supported, making this an effective model for undergraduate health science or medical writing assignments.
Introduction to Ovarian Cancer
Ovarian cancer originates from the ovaries, the egg-producing reproductive organs in women (PubMed Health, 2013). It is the fifth most common type of cancer among women, and the most common subtype — epithelial ovarian cancer — accounts for the majority of all cancer-related deaths from the disease (Jayson et al., 2014). It occurs most frequently among postmenopausal women, who typically first experience abdominal pain and distension (Jayson et al., 2014).
Recent official statistics reveal that 12.3 per 100,000 women develop ovarian cancer every year, and 7.9 per 100,000 die from it annually (SEER, 2012). As of 2011, approximately 188,867 women in the United States were living with this disease. Health experts estimate that about 1.3% of the total population will be diagnosed with ovarian cancer at some point in their lives (SEER, 2012).
Risk Factors
The exact cause of ovarian cancer remains unknown, although several risk factors have been identified (PubMed Health, 2013; Jayson et al., 2014). The risk appears higher in women who have had fewer children, who gave birth later in life, or who have a personal or family history of breast or ovarian cancer — particularly due to defects in the BRCA1 or BRCA2 genes. Additional risk factors include estrogen replacement therapy lasting five or more years and being 55 years of age or older (PubMed Health, 2013; Jayson et al., 2014; Cunningham et al., 2014).
Signs and Symptoms
The symptoms of ovarian cancer are often vague and are frequently attributed to other causes or conditions (PubMed Health, 2013). As a result, the disease has often advanced significantly by the time it is diagnosed. Doctors advise women to seek a medical evaluation when they notice certain symptoms occurring daily and persisting for more than a few weeks.
These symptoms include bloating or a swollen belly, feeling full quickly, pain or heaviness in the lower abdominal area, an abnormal menstrual cycle, digestive disorders, unusual back pain, vaginal bleeding between menstrual periods, and unexplained weight gain or loss. Doctors also caution women about excessive growth of dark or coarse hair and more frequent or urgent urination (PubMed Health, 2013).
Conclusion: The Struggle Continues
A study revealed that most women with ovarian cancer received inadequate treatment from general oncologists rather than from gynecologic oncologists who possess the specialized expertise required for this disease (Editorial Board, 2013). Insufficient patient information contributes to a lack of access to the best available care options. The study found that only slightly more than one-third of patients were provided with the knowledge they needed to make fully informed decisions.
According to this study, 15,000 women die of ovarian cancer each year, most commonly from the epithelial subtype. An analysis of 13,321 cases from 1999 to 2006 showed that 37% received treatment consistent with guidelines established by an alliance of major cancer centers. Surgeons who operated on ten or more ovarian cancer cases and followed these guidelines achieved a five-year survival rate of at least 35% among their patients — compared with only 25% among patients treated by surgeons who did not adhere to the guidelines.
Ovarian cancer patients have historically not received the same level of public attention and advocacy as breast cancer patients. This disparity is particularly troubling given that the five-year survival rate for ovarian cancer, when diagnosed at an early stage, has risen from 74% in 1980 to approximately 99% today (Editorial Board, 2013). Greater awareness, earlier detection, and access to specialized care remain essential goals in improving outcomes for women with this disease.
Always verify citation format against your institution’s current style guide requirements.